Biotechnology Biogen/Eisai’s Popular Alzheimer’s Drug Leqembi Is Seeing Slow Adoption – Here’s Why – Biogen (NASDAQ:BIIB) Read more
Biotechnology Biogen’s Leqembi Commercial Ramp-Up Modest But Up Ticking, Reports Mixed Bag Q1 Earnings Why Is Biogen Stock Trading Higher On Wednesday? – Biogen (NASDAQ:BIIB) Read more